ZA994201B - Nitron compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents
Nitron compounds, a process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA994201B ZA994201B ZA9904201A ZA994201A ZA994201B ZA 994201 B ZA994201 B ZA 994201B ZA 9904201 A ZA9904201 A ZA 9904201A ZA 994201 A ZA994201 A ZA 994201A ZA 994201 B ZA994201 B ZA 994201B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- arylalkyl
- aryl
- Prior art date
Links
- CWGBFIRHYJNILV-UHFFFAOYSA-N (1,4-diphenyl-1,2,4-triazol-4-ium-3-yl)-phenylazanide Chemical class C=1C=CC=CC=1[N-]C1=NN(C=2C=CC=CC=2)C=[N+]1C1=CC=CC=C1 CWGBFIRHYJNILV-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 2
- 150000002460 imidazoles Chemical class 0.000 abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 2
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical group ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9808116A FR2780404B1 (fr) | 1998-06-26 | 1998-06-26 | Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA994201B true ZA994201B (en) | 2000-01-11 |
Family
ID=9527896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9904201A ZA994201B (en) | 1998-06-26 | 1999-06-25 | Nitron compounds, a process for their preparation and pharmaceutical compositions containing them. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6034250A (no) |
| EP (1) | EP0967207B1 (no) |
| JP (1) | JP2000026428A (no) |
| CN (1) | CN1153766C (no) |
| AT (1) | ATE223904T1 (no) |
| AU (1) | AU747203B2 (no) |
| BR (1) | BR9903282A (no) |
| CA (1) | CA2274621C (no) |
| DE (1) | DE69902851T2 (no) |
| DK (1) | DK0967207T3 (no) |
| ES (1) | ES2183492T3 (no) |
| FR (1) | FR2780404B1 (no) |
| HU (1) | HUP9902199A1 (no) |
| NO (1) | NO312722B1 (no) |
| NZ (1) | NZ336460A (no) |
| PT (1) | PT967207E (no) |
| ZA (1) | ZA994201B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096899A (en) * | 1998-04-14 | 2000-08-01 | The Regents Of The University Of Michigan | Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom |
| JP4271445B2 (ja) * | 2001-02-16 | 2009-06-03 | アスビオファーマ株式会社 | Ａｏｐ−１遺伝子又はａｏｐ−１の発現減少を伴う疾患の治療方法及び当該疾患治療薬 |
| WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
| EP2324830A1 (en) * | 2002-03-05 | 2011-05-25 | TransTech Pharma Inc. | Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| JP2005521707A (ja) * | 2002-03-28 | 2005-07-21 | オキシス インターナショナル， インコーポレイテッド | 神経保護方法、組成物、およびそのスクリーニング法 |
| BRPI0410436A (pt) * | 2003-05-20 | 2006-05-30 | Transtech Pharma Inc | antagonistas de rage como agentes para amiloidose reversa e doenças associadas com a mesma |
| CN101468970B (zh) * | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
| TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Ｖｔｖ治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
| JP5885620B2 (ja) * | 2012-08-22 | 2016-03-15 | 四国化成工業株式会社 | ２−（２−フリル）イミダゾール化合物及び酸化防止剤 |
| FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
| FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
| FR3012458B1 (fr) * | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0643403B2 (ja) * | 1986-01-25 | 1994-06-08 | 四国化成工業株式会社 | イミダゾール―アルドキシム化合物の合成方法 |
| US4803282A (en) * | 1986-08-27 | 1989-02-07 | Pennwalt Corporation | Alpha-substituted ketonitrone derivatives |
| CA2111836C (en) * | 1991-06-18 | 2006-08-29 | John M. Carney | Spin-trapping pharmaceutical compositions and methods for use thereof |
| US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
| ATE349420T1 (de) * | 1995-11-17 | 2007-01-15 | Florida Internat University | Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung |
-
1998
- 1998-06-26 FR FR9808116A patent/FR2780404B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-04 CA CA002274621A patent/CA2274621C/fr not_active Expired - Fee Related
- 1999-06-22 JP JP11175839A patent/JP2000026428A/ja active Pending
- 1999-06-23 NO NO19993122A patent/NO312722B1/no not_active IP Right Cessation
- 1999-06-24 EP EP99401565A patent/EP0967207B1/fr not_active Expired - Lifetime
- 1999-06-24 DE DE69902851T patent/DE69902851T2/de not_active Expired - Fee Related
- 1999-06-24 ES ES99401565T patent/ES2183492T3/es not_active Expired - Lifetime
- 1999-06-24 AT AT99401565T patent/ATE223904T1/de not_active IP Right Cessation
- 1999-06-24 PT PT99401565T patent/PT967207E/pt unknown
- 1999-06-24 DK DK99401565T patent/DK0967207T3/da active
- 1999-06-25 US US09/340,088 patent/US6034250A/en not_active Expired - Fee Related
- 1999-06-25 HU HU9902199A patent/HUP9902199A1/hu not_active Application Discontinuation
- 1999-06-25 CN CNB991112148A patent/CN1153766C/zh not_active Expired - Fee Related
- 1999-06-25 NZ NZ336460A patent/NZ336460A/xx unknown
- 1999-06-25 ZA ZA9904201A patent/ZA994201B/xx unknown
- 1999-06-25 BR BR9903282-1A patent/BR9903282A/pt not_active IP Right Cessation
- 1999-06-25 AU AU36800/99A patent/AU747203B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE223904T1 (de) | 2002-09-15 |
| JP2000026428A (ja) | 2000-01-25 |
| NO993122D0 (no) | 1999-06-23 |
| EP0967207A1 (fr) | 1999-12-29 |
| CN1153766C (zh) | 2004-06-16 |
| HU9902199D0 (en) | 1999-08-30 |
| US6034250A (en) | 2000-03-07 |
| FR2780404A1 (fr) | 1999-12-31 |
| FR2780404B1 (fr) | 2001-04-13 |
| DE69902851D1 (de) | 2002-10-17 |
| NO312722B1 (no) | 2002-06-24 |
| DK0967207T3 (da) | 2003-01-20 |
| AU3680099A (en) | 2000-01-13 |
| ES2183492T3 (es) | 2003-03-16 |
| CA2274621A1 (fr) | 1999-12-26 |
| AU747203B2 (en) | 2002-05-09 |
| HUP9902199A1 (hu) | 2000-06-28 |
| DE69902851T2 (de) | 2003-05-28 |
| EP0967207B1 (fr) | 2002-09-11 |
| NZ336460A (en) | 2000-05-26 |
| BR9903282A (pt) | 2000-04-18 |
| CN1245169A (zh) | 2000-02-23 |
| CA2274621C (fr) | 2004-01-20 |
| PT967207E (pt) | 2002-12-31 |
| NO993122L (no) | 1999-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL107426A0 (en) | Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| HU9202656D0 (en) | New thiazole-benzofurane derivatives and method for producing them and pharmaceutical preparatives containing them | |
| HU9700069D0 (en) | Heterocyclic tachykinine-receptor antagonists | |
| HUT40668A (en) | Process for preparing new benzoxazole and amine derivatives and pharmaceutical compositions containing such compounds | |
| ZA994201B (en) | Nitron compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| IL95675A0 (en) | Pyrazole derivatives,processes for preparation thereof and pharmaceutical compositions containing the same | |
| AU5410098A (en) | 1,5-benzodiazepine derivatives | |
| NZ503912A (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists | |
| AP9801321A0 (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives. | |
| HUT42094A (en) | Process for producing new 3-oxadiazol- and 3-carboxylic acid-beta-carbolin derivatives and pharmaceutical compositions containing them | |
| NZ236293A (en) | 1-(alkyl or alkoxyalkyl)-4-phenyl piperidine-4-carboxylic acid amide derivatives; preparatory processes and pharmaceutical compositions | |
| IE872658L (en) | Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them | |
| HUT56547A (en) | Process for producing substituted 1h-imidazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
| PL308635A1 (en) | Glucopyranosidic derivatives of bezothiophenols, pharmaceutical compositions containing them and method of obtaining such derivatives | |
| AU2887584A (en) | 1,5-benzothiazepine derivatives | |
| GB8308601D0 (en) | Heterocyclic compounds | |
| AU8292787A (en) | Fluorine-containing macrolide compounds and their use | |
| KR900014334A (ko) | 신규 화합물 |